iiM portfolio
iiM has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Plastomics's $7.1M Series A round in November 2021, alongside Lewis & Clark AgriFood, Missouri Technology Corporation, Revolution’s Rise of the Rest Seed Fund and 6 others. That company is in Health and bio.
What iiM invests in
- Health and bio · 1 · 100%
- Commerce and retail · 1 · 100%
How iiM invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $7.1M |
iiM portfolio companies
PPlastomics$7.1MSeries A · Nov 2021
| Company | Round with iiM | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $7.1M | $12.9M | Oct 27, 2025 Series B+ |
Most frequent co-investors
MMissouri Technology Corporation1 shared round · last Nov 16, 2021
RRevolution’s Rise of the Rest Seed Fund1 shared round · last Nov 16, 2021
FFulcrum Global Capital1 shared round · last Nov 16, 2021
QQRM Capital1 shared round · last Nov 16, 2021
LLewis & Clark AgriFood1 shared round · last Nov 16, 2021
- CCentennial Investors1 shared round · last Nov 16, 2021
CCIG Spectrum Capital1 shared round · last Nov 16, 2021
TThe Yield Lab1 shared round · last Nov 16, 2021
IiSelect Fund1 shared round · last Nov 16, 2021
Similar investors
AAxiom Asia Private Capital1 company · 1 deal in 12 mo
BBeach Point Capital Management1 company · 1 deal in 12 mo
OOui Capital1 company · 1 deal in 12 mo
RRS Participaties1 company · 1 deal in 12 mo
SSelva Ventures1 company · 1 deal in 12 mo
TTheVentures1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name iiM. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists iiM, which is a subset of its real portfolio. API: /api/v1/investors/iim (get a free API key). More: the most active VC firms and new venture capital funds.